It has been suggested that low plasma levels of APOE are linked to an elevated risk of developing future Alzheimer's disease and all forms of dementia in the general population (Rasmussen et al., 2015). The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.